ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 34211166

Extracellular vesicles as a next-generation drug delivery platform.

Herrmann IK and 2 others. Nat Nanotechnol, 2021. Cited by 1,567 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Extracellular vesicles as a next-generation drug delivery platform. Papers, record 34211166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34211166

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Extracellular vesicles as a next-generation drug delivery platform.
PubMed
Journal
Nat Nanotechnol
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
1,567
iCite
Relative citation ratio, by iCite
102
iCite
Revised in PubMed
2022-05-04
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Herrmann IKInge Katrinhttps://orcid.org/0000-0002-3018-6796
2Wood MJAMatthew John Andrewhttps://orcid.org/0000-0002-5436-6011
3Fuhrmann GGregorhttps://orcid.org/0000-0002-6688-5126

Source PubMed

Topics3

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug Delivery SystemsMajor topic
Extracellular VesiclesMajor topic
Humans

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by1,089

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,567 citations.

PMIDTitleJournalYearIn PapersSource
42,976,073Microfluidic Profiling of an Immune Cell-Associated Extracellular Vesicle Signature for Active Tuberculosis Diagnosis and Treatment Monitoring.J Extracell Vesicles2026https://conductscience.org/library/papers/42976073PubMed
42,975,758Exosome based nanocarriers enabling effective treatment of antimicrobial resistant infections through improved delivery and clinical potential.Discov Nano2026https://conductscience.org/library/papers/42975758PubMed
42,972,439Stem cell-derived exosomes in the therapy of renal diseases: a comprehensive review.Stem Cell Res Ther2026https://conductscience.org/library/papers/42972439PubMed
42,959,456A topologically engineered hydrogel platform targeting IL11 promotes renal repair after partial nephrectomy.Bioact Mater2027https://conductscience.org/library/papers/42959456PubMed
42,953,944Harnessing chemokines and nanocarriers to reprogram the tumor microenvironment.Drug Deliv2026https://conductscience.org/library/papers/42953944PubMed
42,948,342Natural killer cell-derived extracellular vesicles in cancer: mediators of intercellular communication and tumor immune signaling.Front Immunol2026https://conductscience.org/library/papers/42948342PubMed
42,948,205Plant-derived nanovesicles in kidney disease: emerging preclinical evidence and translational challenges.Front Pharmacol2026https://conductscience.org/library/papers/42948205PubMed
42,948,009Metal-organic and covalent organic frameworks for precision drug delivery: a precision-by-design evidence framework for biologically accountable nanomedicine.Front Drug Deliv2026https://conductscience.org/library/papers/42948009PubMed
42,943,300Microglial Therapeutic Potential in Alzheimer's Disease: From Phenotypic Diversity to Targeted Interventions.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42943300PubMed
42,943,276Microneedle-Delivered Plant-Derived Exosome-like Nanovesicles for Dermatological Diseases: A Comprehensive Review.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42943276PubMed

1 to 10 of 1,089

See all 1,089 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34211166

GET https://conductscience.org/api/papers/v1/34211166/cited_by?page=2

API referenceFor AI assistants